Two New Approaches Aim to Limit Weight Regain After Obesity Treatment

Managing weight after obesity treatment presents a significant challenge, with many patients experiencing weight regain due to the "yo-yo effect." This phenomenon, characterized by cycles of weight loss followed by rebound, poses health risks that endocrinologists are working to mitigate with new strategies.

While interventions such as restrictive diets, hormone-based injections like semaglutide (Wegovy) and tirzepatide (Mounjaro), and bariatric surgery have proven effective for initial weight loss, their long-term success is often undermined by improper management after treatment cessation. This can lead to a frustrating cycle of losing and regaining pounds.

Lucie Favre, an endocrinologist at the Lausanne University Hospital (CHUV), explained the detrimental health consequences of this weight cycling. "This yo-yo effect is harmful to health," she stated, noting that rapid weight loss often includes a decrease in muscle mass alongside fat loss. Subsequently, when weight is regained, it tends to be primarily fat, with minimal muscle gain, which negatively alters the body's metabolism and leads to a less favorable body composition after each cycle.

Researchers are exploring innovative approaches to help patients maintain weight loss and avoid the adverse effects of weight cycling. These new strategies aim to provide more sustainable solutions for individuals undergoing obesity treatment, focusing on long-term health and well-being beyond the initial reduction in weight.